SPONSOR
Region Stockholm
Total Trials
13
Recruiting
13
Phases
Phase 3
Conditions studied: Atrial Fibrillation (AF)Platelet Function DisorderPlatelet DisorderThrombocytopathyPost-Intensive Care SyndromeDepressive SymptomsAnxietyPhysical DisabilityPosttraumatic Stress SymptomCritical Care, Intensive Care
Region Stockholm is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Atrial Fibrillation (AF), Platelet Function Disorder, Platelet Disorder, Thrombocytopathy.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Region Stockholm
How many clinical trials has Region Stockholm sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Region Stockholm, of which 13 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation (AF), Platelet Function Disorder, Platelet Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Region Stockholm research focus on?
Region Stockholm clinical trials span Atrial Fibrillation (AF), Platelet Function Disorder, Platelet Disorder, Thrombocytopathy, Post-Intensive Care Syndrome, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Region Stockholm clinical trial?
To participate in a Region Stockholm trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Region Stockholm trials with current recruitment status updated daily.
Clinical Trials by Region Stockholm
NCT07187570 Phase 3
Recruiting
RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
Atrial Fibrillation (AF)
NCT05985668
Recruiting
Towards Improved Diagnostics for Suspected Platelet Function Disorders
Platelet Function Disorder
NCT06118606
Recruiting
Pilot Study of a Multidisciplinary Intervention in ICU Survivors At Risk for Psychological or Physical Morbidity
Post-Intensive Care Syndrome
NCT06576505
Recruiting
Immunological Mechanisms in Sarcoidosis
Sarcoidosis
NCT05679024 Phase 3
Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Chronic Kidney Diseases
NCT06891599
Recruiting
ROTEM in Sepsis Trauma Outcome in Intensive Care
Sepsis - to Reduce Mortality in the Intensive Care Unit
NCT06105502
Recruiting
Systematic Evaluation of Psychotherapy Training: Supervision, Student Learning, and Patient Outcomes
Student Education
NCT05339451
Recruiting
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
Endometriosis
NCT05861752
Recruiting
Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study
Paraphilic Disorders
NCT06643702
Recruiting
Prevalence av BPPV Among Elderly in Primary Care
Benign Paroxysmal Positional Vertigo (BPPV)
NCT06322329
Recruiting
RealMove (Lung): Assessing Tumour Motion With Dynamic MRI
Lung Tumor
NCT05801614
Recruiting
Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction
Diabetes Mellitus Type 2 in Obese
NCT07154758
Recruiting
Registry BAsed Optimization Of Therapy in Heart Failure
Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology